These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures. Ouyang J; Zhang P; Carroll KJ; Lee J; Koch G J Biopharm Stat; 2020 Jul; 30(4):593-606. PubMed ID: 31829826 [TBL] [Abstract][Full Text] [Related]
7. General theory of mixture procedures for gatekeeping. Dmitrienko A; Tamhane AC Biom J; 2013 May; 55(3):402-19. PubMed ID: 23423821 [TBL] [Abstract][Full Text] [Related]
8. Multistage and mixture parallel gatekeeping procedures in clinical trials. Dmitrienko A; Kordzakhia G; Tamhane AC J Biopharm Stat; 2011 Jul; 21(4):726-47. PubMed ID: 21516566 [TBL] [Abstract][Full Text] [Related]
9. Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Traditional multiplicity problems. Paux G; Dmitrienko A J Biopharm Stat; 2018; 28(1):146-168. PubMed ID: 29172961 [TBL] [Abstract][Full Text] [Related]
10. Key multiplicity issues in clinical drug development. Dmitrienko A; D'Agostino RB; Huque MF Stat Med; 2013 Mar; 32(7):1079-111. PubMed ID: 23044723 [TBL] [Abstract][Full Text] [Related]
11. Mixtures of multiple testing procedures for gatekeeping applications in clinical trials. Dmitrienko A; Tamhane AC Stat Med; 2011 Jun; 30(13):1473-88. PubMed ID: 21503948 [TBL] [Abstract][Full Text] [Related]
12. A mixture gatekeeping procedure based on the Hommel test for clinical trial applications. Brechenmacher T; Xu J; Dmitrienko A; Tamhane AC J Biopharm Stat; 2011 Jul; 21(4):748-67. PubMed ID: 21516567 [TBL] [Abstract][Full Text] [Related]
13. Gatekeeping strategies for clinical trials that do not require all primary effects to be significant. Dmitrienko A; Offen WW; Westfall PH Stat Med; 2003 Aug; 22(15):2387-400. PubMed ID: 12872297 [TBL] [Abstract][Full Text] [Related]
14. Managing multiplicity in clinical vaccine studies - A case study using a gatekeeping testing strategy. Wang H; Ypma E; Nicolay U Vaccine; 2022 Apr; 40(16):2462-2469. PubMed ID: 35307233 [TBL] [Abstract][Full Text] [Related]
15. Multiplicity in confirmatory clinical trials: a case study with discussion from a JSM panel. Wang SJ; Bretz F; Dmitrienko A; Hsu J; Hung HM; Koch G; Maurer W; Offen W; O'Neill R Stat Med; 2015 Nov; 34(26):3461-80. PubMed ID: 26112381 [TBL] [Abstract][Full Text] [Related]
16. Superchain procedures in clinical trials with multiple objectives. Kordzakhia G; Dmitrienko A Stat Med; 2013 Feb; 32(3):486-508. PubMed ID: 22903837 [TBL] [Abstract][Full Text] [Related]
18. Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpoints. Sun H; Snyder E; Koch GG J Biopharm Stat; 2018; 28(1):189-211. PubMed ID: 28992425 [TBL] [Abstract][Full Text] [Related]
19. Stepwise gatekeeping procedures in clinical trial applications. Dmitrienko A; Tamhane AC; Wang X; Chen X Biom J; 2006 Dec; 48(6):984-91. PubMed ID: 17240656 [TBL] [Abstract][Full Text] [Related]
20. A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks. Tamhane AC; Gou J; Jennison C; Mehta CR; Curto T Biometrics; 2018 Mar; 74(1):40-48. PubMed ID: 28589692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]